Jeito is a leading international investment firm with a focus on revolutionizing healthcare for the benefit of patients. They adopt a patient-centric approach and provide significant capital investments to support and accelerate cutting-edge medical innovations. Jeito's multidisciplinary team of experts is dedicated to fostering growth across the entire value chain of the pharmaceutical industry, enabling the emergence of leaders in specific therapeutic fields.

Their efforts contribute to expediting the market launch of innovative treatments worldwide, particularly in Europe and the United States, benefiting patients in need. With years of experience in the health sector, Jeito has built an impressive portfolio and currently manages millions of euros in assets. Based in Paris, Jeito has a presence in Europe and the United States.

They have recently led several funding rounds for groundbreaking biopharmaceutical companies, reinforcing their commitment to advancing medical innovation